Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor‐based combination therapies for hepatocellular carcinoma
Zhi‐Cheng Jin, Jian‐Jian Chen, Biao Luo, Wei‐Hua Zhang, Gao‐Jun Teng – 14 July 2022
Multicenter assessment of hypertension management among liver transplantation recipients
Sneha Chebrolu, Meaghan Phipps, Frederick Yao, Jennifer Lai, Elizabeth Verna, Marina Serper, Giuseppe Cullaro, Sumeet K. Asrani, Lisa B. VanWagner – 14 July 2022
Issue Information ‐ Author Checklist
14 July 2022
Issue Information
14 July 2022
Issue Information
14 July 2022
Inhibition of mPGES‐2 ameliorates NASH by activating NR1D1 via heme
Dandan Zhong, Jie Cai, Cheng Hu, Jingshuo Chen, Rumeng Zhang, Chenyu Fan, Shanshan Li, Hongxing Zhang, Zhou Xu, Zhanjun Jia, Dong Guo, Ying Sun – 14 July 2022
Issue Information
14 July 2022
Reply: Change in serial liver stiffness measurement by MR elastography and outcomes in NAFLD
Tolga Gidener, Ross Dierkhising, Kristin C. Mara, Terry M. Therneau, Sudhakar K. Venkatesh, Richard L. Ehman, Meng Yin, Alina M. Allen – 13 July 2022
Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans
Elke Ericson, Linnéa Bergenholm, Anne‐Christine Andréasson, Carly I. Dix, Jane Knöchel, Sara F. Hansson, Richard Lee, Jennifer Schumi, Madeleine Antonsson, Ola Fjellström, Patrik Nasr, Mathias Liljeblad, Björn Carlsson, Stergios Kechagias, Daniel Lindén, Mattias Ekstedt – 13 July 2022 – In nonalcoholic fatty liver disease (NAFLD) the patatin‐like phospholipase domain‐containing 3 (PNPLA3) rs738409 variant is a contributor.